| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2a714c765a7fc341974b3b936a00f0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29e307166bd42ff218bcceb8e166d0fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
| filingDate |
2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a43beda1725ee6414eb5bf3af04aeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c334653b71874c5078e506ebf1053743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ba85922f82e35aaf291e09ecaa689f |
| publicationDate |
2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-3097573-A1 |
| titleOfInvention |
ORAL FORM OF MIFEPRISTONE FOR USE IN CERVICAL RIPENATION AND ARTIFICIAL INCDUCTION OF LABOR |
| abstract |
The invention relates to an oral dosage form of mifepristone of mifepristone oral formulation characterised in that said formulation comprises an amount selected from the group consisting of 75mg, 150 mg or 300 mg mifepristone, and said formulation is for its use in the induction of labour and cervix ripening in a woman being at least 37 weeks pregnant. |
| priorityDate |
2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |